Results 31 to 40 of about 34,933 (276)

Coexisting primary Sjögren’s syndrome and sarcoidosis: coincidence, mutually exclusive conditions or syndrome? [PDF]

open access: yes, 2014
Herein, we describe a 44-year-old female diagnosed with histologically proven coexistence of primary Sjögren's syndrome and sarcoidosis with pulmonary and muscular involvement.
Duarte, C   +6 more
core   +1 more source

Beyond the glands; A toll for the forgotten thirst

open access: yesAPIK Journal of Internal Medicine, 2019
Sjogren's syndrome, an autoimmune disease of exocrine glands presents in different ways. The disease can present as a single when it is called primary Sjogren's syndrome or may be associated with other autoimmune disorders when it is termed as secondary ...
T R Sowmya, K Ravi
doaj   +1 more source

Higher Risk for Sjögren’s Syndrome in Patients With Fibromyalgia: A Nationwide Population-Based Cohort Study

open access: yesFrontiers in Immunology, 2021
ObjectivesClinically, associations have been observed between Sjögren’s syndrome and fibromyalgia. Nonetheless, population-based evidence evaluating the risk of Sjögren’s syndrome in fibromyalgia patients is lacking.
Shuo-Yan Gau   +10 more
doaj   +1 more source

Analysis of SIGLEC1 as a surrogate marker for a type I interferon signature in autoimmune congenital heart block and primary Sjögren’s syndrome [PDF]

open access: yes, 2019
Interferon-α (IFN-α), belonging to the family of type I interferons, is a cytokine involved in the pathogenesis of many autoimmune diseases, including systemic lupus erythematosus (SLE) and primary Sjögren’s syndrome (pSS).
Lisney, Anna
core   +1 more source

Histopathology and immunopathology in minor salivary glands of patients with Sjögren's syndrome (SSj) [PDF]

open access: yes, 2005
Sjögren's syndrome (SSj) is a chronic autoimmune disorder characterized by lymphocytic infiltration of the exocrine glands with concomitant destruction of the glandular tissue, affecting predominantly salivary and lacrimal glands.
Andrade, Luiz Eduardo Coelho   +1 more
core   +2 more sources

The role of nailfold capillaroscopy in interstitial lung diseases - Can it differentiate idiopathic cases from collagen tissue disease associated interstitial lung diseases? [PDF]

open access: yes, 2015
Introduction: Nailfold capillaroscopy (NFC) is a non-invasive diagnostic test that is mostly used for early diagnosis of collagen tissue diseases (CTDs). We aimed to evaluate whether NFC findings could be a clue for discriminating idiopathic interstitial
Altınışık, Göksel   +4 more
core   +1 more source

DIAGNOSIS OF THE SYNDROME OF SCHEGREN. REVIEW

open access: yesМедична наука України, 2018
Relevance. Sjogren's syndrome is included in the group of diffuse connective tissue diseases and ranks third among them. Sjögren's syndrome remains unidentified in half the cases of the disease with clinical manifestations.
D.V. Topchy
doaj   +1 more source

Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjögren syndrome. Report of two cases and review of literature [PDF]

open access: yes, 2015
Background: Inteleukin (IL)12 and IL23 are two main cytokines involved in the pathogenesis of immune-mediated disease. IL12 is produced by macrophages and B lymphocytes and mediates differentiation of Th1 lymphocytes, while IL23 is a pro-inflammatory ...
Chimenti, MS   +6 more
core   +1 more source

COVID-19 and chronological aging : senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? [PDF]

open access: yes, 2020
COVID-19, also known as SARS-CoV-2, is a new emerging zoonotic corona virus of the SARS (Severe Acute Respiratory Syndrome) and the MERS (Middle East Respiratory Syndrome) family.
Auwerx   +30 more
core   +2 more sources

Patient reported outcome and experience measures of oral disease in oral medicine [PDF]

open access: yes, 2017
A recent meeting of health ministers from over 40 countries worldwide deemed that time and money should be spent on outcome and experience measures that would allow us to determine whether our health systems deliver outcomes that truly matter to patients.
Ni Riordain, R, Wiriyakijja, P
core   +1 more source

Home - About - Disclaimer - Privacy